Internal Control · 2025
In this section8 topics
- Adequacy & Appropriateness of the Internal Control System1 item
- Internal Control Deficiencies1 item
- Audit Committee & Auditor Observations3 items
- Opinion on the Head of Internal Audit2 items
- Appointment, Discharge & Transfer of the Head of Internal Audit2 items
- Related Party Transactions2 items
- Counterparties & Transactions3 items
- Policy & Future Trends1 item
Adequacy & Appropriateness of the Internal Control System
Internal Control Framework Used
| Framework | Detail |
|---|---|
| COSO - Enterprise Risk Management Framework (ERM) | The Company has adopted the COSO Internal Control Framework as a guideline for designing, developing, and evaluating its internal control system, covering the following five key components: (1) Control EnvironmentThe Board of Directors is committed to fostering an organizational culture founded on integrity, ethics, and accountability, while overseeing the Company’s operations to ensure compliance with applicable laws and alignment with the Company’s objectives and goals. Key practices include the following: Corporate Governance and Ethics Policy Goal Setting and Management Organizational Structure and Segregation of Duties (2) Risk AssessmentThe Company has established a systematic process for identifying and assessing risks and uses such information as a basis for proactive risk management in order to prevent or mitigate potential impacts arising from events or circumstances that may affect the achievement of the Company’s objectives and goals, whether from internal or external factors that are constantly changing. The key objectives of the risk assessment process are to:
The Company is committed to applying corporate governance principles and risk management practices to support its organizational goals by aiming to:
In this regard, the Company has established risk management policies and practices and reviews and updates them regularly to keep pace with changes in the business environment. The Company applies the JCI standards and COSO 2017 Enterprise Risk Management framework to its enterprise risk management process. All employees are responsible for managing risks within the scope of their duties, while executives in each function are responsible for overseeing the risk management process at both the strategic and business process levels to ensure that it is conducted appropriately and effectively. (3) Control ActivitiesThe Company has established appropriate control measures to help reduce risks that may affect the achievement of organizational objectives to an acceptable level, taking into account the nature of work, complexity, environment, and the specific characteristics of the business. The Company has prepared written policies and operating procedures, and regularly reviews them to ensure consistency with changing business conditions. These cover key areas such as:
In addition, the Company has clearly defined management authority and approval limits at each level under the delegation of authority policy approved by the Board of Directors, while also emphasizing appropriate segregation of duties, such as:
Such segregation of duties promotes checks and balances, reducing the likelihood of errors or inappropriate acts. The Company has also established strict controls for monitoring and overseeing transactions involving major shareholders, directors, executives, or related persons to ensure that such transactions are conducted in accordance with clearly prescribed procedures and approval processes, and to prevent conflicts of interest, with the Company’s best interests as the primary consideration. (4) Information and CommunicationThe Company places importance on information systems and communication in support of the operations and decision-making of the Board of Directors, management, shareholders, and relevant parties, with emphasis on ensuring that information is accurate, complete, timely, and sufficient for effective decision-making. Key practices include the following: 1. Transparent and Systematic Information Management
2. Internal Communication Channels
3. Communication with Stakeholders 4. Whistleblowing and Complaint System
5. Modern and Secure Information Systems 6. Information and Communication Training (5) Monitoring ActivitiesThe Company has clear systems and processes for continuously monitoring and evaluating its internal control system to ensure that it remains effective and efficient. This covers the following key areas: 1. Ongoing Monitoring
2. Periodic Evaluation 3. Error and Weakness Management
4. Ethical Compliance Monitoring
5. Significant Incident Reporting
6. External Assessment 7. Data and Record Management |
Internal Control Deficiencies
Number of Deficiencies
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of internal control system deficiencies (cases) | 0 | 0 | 0 |
Audit Committee & Auditor Observations
Introduction
At its Meeting No. 1/2025 held on 14 February 2025, the Audit Committee reviewed the Company’s internal control system by making inquiries with management and considering relevant information. The Committee concluded that the Company’s internal control system was adequate and appropriate, covering the five key components, namely: control environment, risk assessment, control activities, information and communication, and monitoring activities.
The Audit Committee was of the opinion that the Company had assigned sufficient personnel to effectively implement the internal control system and had established an appropriate and adequate monitoring and supervisory process. In addition, with respect to other aspects of internal control, the Audit Committee also considered that the Company had put in place appropriate and sufficient internal control measures.
Based on its assessment of the internal control system in the above areas, the Audit Committee did not identify any significant issues or material deficiencies. This was consistent with the opinion of the external auditor that the Company’s internal control system was adequate and effective for the conduct of its business.
In addition, the Company’s external auditor reviewed and assessed the accounting controls of the Company and its subsidiaries and did not identify any material weaknesses that could significantly affect the auditor’s opinion on the consolidated financial statements of the Group for the year ended 31 December 2025.
Accordingly, the Audit Committee concurred with the external auditor’s opinion that the Company’s internal control system was adequate and appropriate for its business operations and was capable of safeguarding the Company’s assets from improper or unauthorized use by management.
Audit Committee's Opinion Differs from the Board's
No
Auditor Has Observations on Internal Control
No
Opinion on the Head of Internal Audit
Head of Internal Audit
3159
Audit Committee's Opinion on the Head of Internal Audit
The Internal Audit Department is independent from management and reports directly to the Audit Committee with respect to internal audit activities. The objectives, authority, responsibilities, as well as the roles and duties of the Head of Internal Audit are clearly defined in the Internal Audit Charter. In this regard, the Internal Audit Department adheres to the International Standards for the Professional Practice of Internal Auditing, relevant requirements of professional associations, and the Company’s internal audit procedures.
The Audit Committee receives internal audit reports, management’s progress in implementing corrective actions, and updates on the performance of the Internal Audit Department on a regular basis for use in overseeing and monitoring the adequacy of the Company’s internal control system and risk management.
Audit Committee’s Opinion on the Appointment of the Head of Internal Audit
The Audit Committee has considered the qualifications, knowledge, capabilities, experience, independence in the performance of duties, and performance results of the Head of Internal Audit, and is of the opinion that Ms. Julalak Boonrit is qualified and appropriate to serve as the Head of Internal Audit of the Company. She is able to perform her duties independently and objectively, in accordance with the Internal Audit Charter and relevant professional internal auditing standards.
The Audit Committee is also of the opinion that the Head of Internal Audit is capable of appropriately planning and carrying out internal audit activities based on a risk-based audit approach, reporting audit results, observations, and recommendations to the Audit Committee completely and regularly, and continuously following up on management’s corrective actions. This has been beneficial to strengthening the Company’s internal control system, risk management, and good corporate governance.
Accordingly, the Audit Committee has approved the continuation of Ms. Julalak Boonrit in her position as the Head of Internal Audit of the Company.
Appointment, Discharge & Transfer of the Head of Internal Audit
Requires Audit Committee Approval
Yes
Description
The Company has stipulated in the Audit Committee Charter that the Audit Committee is responsible for reviewing whether the Company has appropriate and effective internal control and internal audit systems, considering the independence of the internal audit function, and approving the appointment, transfer, removal, or termination of the Head of Internal Audit or any other person responsible for internal audit activities.
In this regard, the Company requires that any appointment, removal, or transfer of the Head of Internal Audit must receive prior approval from the Audit Committee in all cases. The Audit Committee considers the individual’s qualifications, knowledge, capabilities, experience, independence, and suitability for the role to ensure that the Head of Internal Audit is able to perform duties objectively, independently, and in accordance with professional internal auditing standards and the Internal Audit Charter.
Any removal or transfer shall be carried out on the basis of appropriate, transparent, and verifiable reasons, with due consideration given to its impact on the independence and effectiveness of the Internal Audit Department.
Related Party Transactions
Introduction
The Company has entered into connected transactions with persons who may have conflicts of interest, including directors, shareholders, executives, and related juristic persons. Such related juristic persons mean juristic persons in which persons who may have conflicts of interest with the Company are involved or have relationships with the directors, executives, or shareholders of such juristic persons. In this regard, the Company has summarized the nature of the relationships of the relevant persons and juristic persons as set out below.
Has Related Party Transactions
Yes
Counterparties & Transactions
Monetary Unit
1
Counterparties with Potential Conflicts
| Name | Person / Juristic Person | Type of Business | Nature of Relationship | As of Date (YYYY-MM-DD) |
|---|---|---|---|---|
| Teerawat Micro clinic | Person | Relationship with director | 2025-12-31T00:00 | |
| Finehouse Catering Co.,Ltd. | Juristic Person | Restaurants activities | Relationship with director | 2025-12-31T00:00 |
| Mr.Boonsong Jenwechprasert | Person | Shareholder and relationship with management | 2025-12-31T00:00 | |
| Raktam Srinakarin | Person | Shareholder and Relationship with director | 2025-12-31T00:00 | |
| Associate Professor Srichai Krusun, M.D. | Person | Board of Director | 2025-12-31T00:00 | |
| Associate Professor Jiraporn Srinakarin, M.D. | Person | Shareholder and relationship with director | 2025-12-31T00:00 | |
| Kaen Pa Nga Company Limited | Juristic Person | Operates medical facilities, including surgical and aesthetic clinics, providing surgical procedures and a comprehensive range of healthcare and medical treatment services. | The Subsidiary | 2025-12-31T00:00 |
Transactions by Counterparty
| Transactions |
|---|
| 0.0 · Necessity: Teerawat Micro Clinic referred a client to Ratchaphruek Hospital for a nasal X-ray before undergoing surgery. The company charged Teerawat Micro Clinic for the nasal X-ray service at a rate comparable to what the company charged general patients who used the service. · Description: Providing nasal x-ray services · As of yesteryear: 2124.0 · Nature of transaction: Revenues from hospital operations · Audit committee opinion: The aforementioned transactions are necessary and reasonable and the purchase and sale prices are in accordance with market conditions, are normal business transactions with general trading conditions and have been approved in principle by the Audit Committee and the Board of Directors. · As of year before yesteryear: 13700.0 |
| 14985344.0 · Necessity: The Company entered into a contract to assemble and purchase ready-to-eat food from Mr. Warong Laopaiboon for inpatient services (IPD). The contract is effective from August 1, 2023 to July 31, 2024 and will be renewed for 1-year periods unless the contracting party notifies the intention to terminate the contract. · Description: Company that hires to assemble and purchase ready-to-eat food · As of yesteryear: 15140907.0 · Nature of transaction: Cost of hospital operations · Audit committee opinion: For this transaction, it is considered necessary and reasonable as the Company needs to hire, prepare and purchase food for patient service. The Company has arranged a competitive bidding to select a restaurant and outsiders have joined in offering cooking services. The purchase price between the two parties is in accordance with market conditions and is a normal business transaction with general trading conditions. The Audit Committee will consider the transaction conditions every year before renewing the annual contract. · As of year before yesteryear: 14687256.0 · 493752.0 · Necessity: The Company entered into an agreement with Mr. Worong Laophaiboon for the preparation and purchase of ready-to-eat meals for patient services. The agreement became effective on 1 August 2023 and expired on 31 July 2024. Thereafter, it shall be automatically renewed for successive one-year terms unless either party notifies the other of its intention to terminate the agreement. · Description: Company that hires to assemble and purchase ready-to-eat food · As of yesteryear: 457524.0 · Nature of transaction: Other income · Audit committee opinion: The transaction is necessary and reasonable, as the Company is required to engage catering services and procure meals for patient services. The Company has conducted a competitive bidding process to select the food service provider, in which external parties also participated in submitting proposals for meal preparation services. In this regard, the transaction price is based on market terms and constitutes an ordinary business transaction under general commercial conditions. The Audit Committee will review the terms and conditions of the transaction annually prior to each yearly renewal of the agreement. · As of year before yesteryear: 154910.0 · 42849.0 · Necessity: The Company entered into a contract to assemble and purchase ready-to-eat food from Mr. Warong Laopaiboon for patient services (IPD), with the contract effective from August 1, 2023 and ending on July 31, 2024, and will be renewed for 1-year periods unless the contracting party gives notice of intent to terminate the contract. · Description: Company that hires to assemble and purchase ready-to-eat food · As of yesteryear: 40129.0 · Nature of transaction: Trade and other current receivables · Audit committee opinion: For this transaction, it is considered necessary and reasonable as the Company needs to hire, prepare and purchase food for patient service. The Company has arranged a competitive bidding to select a restaurant and outsiders have joined in offering cooking services. The purchase price between the two parties is in accordance with market conditions and is a normal business transaction with general trading conditions. The Audit Committee will consider the transaction conditions every year before renewing the annual contract. · As of year before yesteryear: 38188.0 · 587051.0 · Necessity: The Company entered into a contract to assemble and purchase ready-to-eat food from Mr. Warong Laopaiboon for inpatient services (IPD). The contract is effective from August 1, 2023 to July 31, 2024 and will be renewed for 1-year periods unless the contracting party notifies the intention to terminate the contract. · Description: Company that hires to assemble and purchase ready-to-eat food · As of yesteryear: 502120.0 · Nature of transaction: Trade and other current payables · Audit committee opinion: For this transaction, it is considered necessary and reasonable as the Company needs to hire, prepare and purchase food for patient service. The Company has arranged a competitive bidding to select a restaurant and outsiders have joined in offering cooking services. The purchase price between the two parties is in accordance with market conditions and is a normal business transaction with general trading conditions. The Audit Committee will consider the transaction conditions every year before renewing the annual contract. · As of year before yesteryear: 492057.0 |
| 129600.0 · Necessity: The Company has entered into a contract to lease advertising space with Mr. Boonsong Jenwechprasirt, with the contract effective from January 1, 2025 and ending on December 31, 2025. (It is a lease contract that is considered for renewal on an annual basis with the same conditions.) · Description: Rent advertising space · As of yesteryear: 129600.0 · Nature of transaction: Rental and utility expenses · Audit committee opinion: The said items are necessary and reasonable and subject to normal trading conditions. · As of year before yesteryear: 97200.0 · 10800.0 · Necessity: The Company has entered into a contract to lease advertising space with Mr. Boonsong Jenwechprasirt, with the contract effective from January 1, 2025 and ending on December 31, 2025. (It is a lease contract that is considered for renewal on an annual basis with the same conditions.) · Description: Rent advertising space · As of yesteryear: 10800.0 · Nature of transaction: Trade and other payable · Audit committee opinion: The said items are necessary and reasonable and subject to normal trading conditions. · As of year before yesteryear: 10800.0 |
| 800552.0 · Necessity: This transaction involves the design and tailoring of work uniforms for office staff and the design of uniforms for clinical personnel, in line with the Company’s policy to revise employee uniform styles in 2025. · Description: Design and tailor uniforms for company employees. · As of yesteryear: 246620.0 · Nature of transaction: Service fee · Audit committee opinion: The connected transaction was entered into in the ordinary course of the Company’s business and is considered reasonable. · As of year before yesteryear: 0.0 · 0.0 · Necessity: This transaction involves the design and tailoring of work uniforms for office staff and the design of uniforms for clinical personnel, in line with the Company’s policy to revise employee uniform styles in 2025. · Description: Design and tailor uniforms for company employees. · As of yesteryear: 39900.0 · Nature of transaction: Trade and other current payables · Audit committee opinion: Such related transactions are in line with the Company's normal business and are reasonable. · As of year before yesteryear: 0.0 |
| 186300.0 · Necessity: The doctors who hold the position of board member will provide treatment to patients at Ratchaphruek Hospital. The compensation is comparable to the service rates that the company pays to other doctors with similar qualifications. · Description: Doctor fee · As of yesteryear: 190250.0 · Nature of transaction: Cost of hospital operations · Audit committee opinion: Such transactions are necessary and reasonable, and the Company is required to pay remuneration to the said doctor at a rate equivalent to other doctors with similar qualifications to the doctor who holds the said directorship position. · As of year before yesteryear: 217300.0 · 16252.0 · Necessity: The doctors who hold the position of board member will provide treatment to patients at Ratchaphruek Hospital. The compensation is comparable to the service rates that the company pays to other doctors with similar qualifications. · Description: Doctor fee · As of yesteryear: 12116.0 · Nature of transaction: Trade and other current payables · Audit committee opinion: Such transactions are necessary and reasonable, and the Company is required to pay remuneration to the said doctor at a rate equivalent to other doctors with similar qualifications to the doctor who holds the said directorship position. · As of year before yesteryear: 20094.0 |
| 189410.0 · Necessity: Executive doctors treat patients at Ratchaphruek Hospital, with compensation comparable to the service rates paid by the company to other doctors with similar qualifications. · Description: Doctor fee · As of yesteryear: 126710.0 · Nature of transaction: Cost of hospital operations · Audit committee opinion: The said transaction is necessary and reasonable. The Company is required to pay compensation to the doctor at a rate equivalent to other doctors with similar qualifications to the doctor who holds the said executive position. · As of year before yesteryear: 114010.0 · 27562.0 · Necessity: Executive doctors treat patients at Ratchaphruek Hospital, with compensation comparable to the service rates paid by the company to other doctors with similar qualifications. · Description: Doctor fee · As of yesteryear: 8560.0 · Nature of transaction: Trade and other current payables · Audit committee opinion: The said transaction is necessary and reasonable. The Company is required to pay compensation to the doctor at a rate equivalent to other doctors with similar qualifications to the doctor who holds the said executive position. · As of year before yesteryear: 4738.0 |
Policy & Future Trends
Policy, Measures & Approval Process
Related Party Transaction Policy and Approval Procedures
1. The Company adheres to the regulations of the Stock Exchange of Thailand regarding related party transactions and/or acquisitions or disposals of assets by listed companies. The Company discloses relevant information to shareholders, general investors, and relevant agencies, including the Stock Exchange of Thailand, and obtains approval from the Board of Directors and/or the shareholders meeting as required by the Stock Exchange of Thailand.
2. The Company has defined policies for related party transactions, including purchase prices, sale prices, and transaction values, which are subject to normal trading conditions. The Audit Committee reviews and follows procedures to ensure the reasonableness of the transactions for the benefit of the Company. The prices or rates of such transactions are reviewed with Company employees and internal auditors to ensure they are reasonable, and the financial statements reflect accurate disclosures.
3. The Company has approval procedures for related party transactions, which are carried out similarly to general procurement processes. Executives or shareholders with an interest in the transaction do not participate in the approval process.
4.For non-normal transactions that do not meet the size threshold for shareholder approval under the Stock Exchange of Thailand's regulations, the CEO has the authority to approve the transactions.
5. However, if the size of the related party transaction exceeds the CEO’s approval authority, the CEO will summarize and present the transaction for further approval by the Board of Directors.
In 2025, the Company did not receive any warnings regarding violations related to related party transactions or asset sales that were in breach of or did not comply with the regulations of the Stock Exchange of Thailand and the Securities and Exchange Commission (SEC). Full details of the Connected and transaction policy can be found on the Company’s website in the Investor Relations section under the Corporate Governance Policy.

